LOGIN  |  REGISTER
Amneal Pharmaceuticals

Recent Insider Transactions - Context Therapeutics (NASDAQ: CNTX)

Follow NASDAQ:CNTX Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ CNTX Context Therapeutics
Pasternak Andy / director
06/12/2025
Buy
$0.65
138,900
$91K
138,900
NASDAQ CNTX Context Therapeutics
Kantoff Philip W. / director
06/12/2025
Buy
$0.65
123,500
$81K
123,500
NASDAQ CNTX Context Therapeutics
Smith Karen L. / director
06/12/2025
Buy
$0.65
123,500
$81K
123,500
NASDAQ CNTX Context Therapeutics
Stacey Jennifer Evans / director
06/12/2025
Buy
$0.65
123,500
$81K
123,500
NASDAQ CNTX Context Therapeutics
Walker Luke Nathaniel / director
06/12/2025
Buy
$0.65
123,500
$81K
123,500
NASDAQ CNTX Context Therapeutics
West Linda / director
06/12/2025
Buy
$0.65
123,500
$81K
123,500
NASDAQ CNTX Context Therapeutics
Lehr Martin A. / director, officer: Chief Executive Officer
06/09/2025
Buy
$0.70
100,000
$70K
920,190
NASDAQ CNTX Context Therapeutics
Levit Alex C. / officer: Chief Legal Officer, Corp. Sec
06/06/2025
Buy
$0.58
20,000
$12K
29,000
NASDAQ CNTX Context Therapeutics
Minai-Azary Jennifer Lynn / officer: Chief Financial Officer
06/06/2025
Buy
$0.64
40,010
$25K
80,010
NASDAQ CNTX Context Therapeutics
Chagin Karen Deborah / officer: Chief Medical Officer
06/09/2025
Buy
$0.70
153,000
$108K
153,000

  Research Tools
  News & Announcements
  Popular Topics
  Miscellaneous